Literature DB >> 24788503

Is limb salvage surgery safe for bone sarcomas identified after a previous surgical procedure?

C L Gaston1, T Nakamura, K Reddy, A Abudu, S Carter, L Jeys, R Tillman, R Grimer.   

Abstract

Bone sarcomas are rare cancers and orthopaedic surgeons come across them infrequently, sometimes unexpectedly during surgical procedures. We investigated the outcomes of patients who underwent a surgical procedure where sarcomas were found unexpectedly and were subsequently referred to our unit for treatment. We identified 95 patients (44 intra-lesional excisions, 35 fracture fixations, 16 joint replacements) with mean age of 48 years (11 to 83); 60% were males (n = 57). Local recurrence arose in 40% who underwent limb salvage surgery versus 12% who had an amputation. Despite achieving local control, overall survival was worse for patients treated with amputation rather than limb salvage (54% vs 75% five-year survival). Factors that negatively influenced survival were invasive primary surgery (fracture fixation, joint replacement), a delay of greater than two months until referral to our oncology service, and high-grade tumours. Survival in these circumstances depends mostly on factors that are determined prior to definitive treatment by a tertiary orthopaedic oncology unit. Limb salvage in this group of patients is associated with a higher rate of inadequate marginal surgery and, consequently, higher local recurrence rates than amputation, but should still be attempted whenever possible, as local control is not the primary determinant of survival.

Entities:  

Keywords:  Bone; Inadvertent; Inappropriate; Sarcoma; Surgery

Mesh:

Year:  2014        PMID: 24788503     DOI: 10.1302/0301-620X.96B5.33140

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  8 in total

1.  Comparable outcomes of recycled autografts and allografts for reconstructions in patients with high-grade osteosarcoma.

Authors:  Kuan-Lin Chen; Chao-Ming Chen; Cheng-Fong Chen; Yu-Chi Cheng; Yu-Kuan Lin; Shang-Wen Tsai; Tain-Hsiung Chen; Po-Kuei Wu; Wei-Ming Chen
Journal:  Int Orthop       Date:  2021-08-19       Impact factor: 3.075

2.  Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group.

Authors:  Tomoki Nakamura; Jun Sugaya; Norifumi Naka; Hiroshi Kobayashi; Tomotake Okuma; Toshiyuki Kunisada; Kunihiro Asanuma; Hedetatsu Outani; Shunji Nishimura; Hiroyuki Kawashima; Toru Akiyama; Taketoshi Yasuda; Shinji Miwa; Akihiro Sudo; Takafumi Ueda
Journal:  Cancer Manag Res       Date:  2020-10-12       Impact factor: 3.989

Review 3.  Amputation Versus Limb-Salvage Surgery in Patients with Osteosarcoma: A Meta-analysis.

Authors:  Gang Han; Wen-Zhi Bi; Meng Xu; Jin-Peng Jia; Yan Wang
Journal:  World J Surg       Date:  2016-08       Impact factor: 3.352

4.  Effect of Unplanned Therapy on the Prognosis of Patients with Extremity Osteosarcoma.

Authors:  Bing Wang; Ming Xu; Kai Zheng; Xiuchun Yu
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

5.  Malignant tumours of the foot and ankle.

Authors:  E Mascard; N Gaspar; L Brugières; C Glorion; S Pannier; A Gomez-Brouchet
Journal:  EFORT Open Rev       Date:  2017-05-11

Review 6.  A meta-analysis of randomized control trials of surgical methods with osteosarcoma outcomes.

Authors:  Xiaojun He; Zhenzhen Gao; Hongwei Xu; Zhongwei Zhang; Peng Fu
Journal:  J Orthop Surg Res       Date:  2017-01-13       Impact factor: 2.359

7.  Treatment-Related Prognostic Factors in Managing Osteosarcoma around the Knee with Limb Salvage Surgery: A Lesson from a Long-Term Follow-Up Study.

Authors:  Jianping Hu; Chunlin Zhang; Kunpeng Zhu; Lei Zhang; Tao Cai; Taicheng Zhan; Xiong Luo
Journal:  Biomed Res Int       Date:  2019-05-02       Impact factor: 3.411

8.  Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12, a Novel Non-High-Dose Methotrexate-Based, Dose-Dense Combination Chemotherapy, in a Tertiary Care Cancer Center.

Authors:  Jyoti Bajpai; Arun Chandrasekharan; Vijai Simha; Vikas Talreja; Ashay Karpe; Nikihil Pandey; Ashish Singh; Bharat Rekhi; Tushar Vora; Jaya Ghosh; Shripad Banavali; Sudeep Gupta
Journal:  J Glob Oncol       Date:  2018-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.